About this event

  • Date and time Thu 12 Nov 2020 from 6:00pm to 8:00pm
  • Location Online
  • Organised by Ophthalmology

This webinar will review the history of retinal surgery and enlighten participants on new developments in the field. Expert speakers will guide participants through this rapidly developing and exciting specialty, and will discuss how modern surgical practice is changing the outlook for patients with previously untreatable conditions.

Topics of new developments include:

  • Robotic surgery and 3D viewing systems
  • Small gauge vitrectomy
  • Complex pathology/K-Pro combination cases
  • Secondary intra-ocular lenses from the Vitreoretinal viewpoint
  • Developments and success in retinopathy of prematurity surgery
  • New frontiers in gene therapy and viral vector delivery

During this webinar you will:

  • Have an overview of past evolution and previous developments in VR surgery
  • Be able to list and describe new developments in the field
  • Gain confidence in expanding own clinical practice
  • Discover new treatment opportunities and referral possibilities for patients

This webinar will particularly interest ophthalmologists of all levels and any medical students interested in eye treatments.

Join in the conversation online by using #RSMLive 
Follow us on Twitter: @RoySocMed

Key speakers

Evgenia Anikina

Ms Evgenia Anikina

Consultant retinal surgeon, Royal Berkshire NHS Trust

Speaker's biography

Ms Evgenia Anikina was educated in Cambridge, gaining a first class degree and consequently completed her specialist ophthalmology training in London. She undertook two surgical retinal fellowships and a medical retina fellowship at Moorfields Eye Hospital prior to being appointed as a Consultant Vitreoretinal Surgeon at the Royal Berkshire NHS Trust.

She has been the recipient of a number of prizes and awards and has held several additional roles, including being a member of a medical ethics committee, serving as a medical representative for Great Britain for an international sporting federation and having a position on the Council of the Ophthalmology Section of the RSM.

She is passionate about education and has been involved extensively with teaching and training. This experience has included a College Supervisor role at the University of Cambridge, serving on the clinical skills faculty for the RCOphth and being a College examiner.

Louisa Wickham

Ms Louisa Wickham

Consultant retinal surgeon, Moorfields Eye Hospital

Speaker's biography

Louisa Wickham has been a full-time consultant at Moorfields since 2009 and was appointed Chief Surgeon in 2019. Louisa has a research degree in the surgical management of retinal detachment and post-operative scarring and trained in both Vitreoretinal Surgery and Medical Retinal disorders. She has particular specialist interest in the surgical management of diabetic eye disease including early surgical intervention. Louisa has also developed an interest in secondary lens insertion with a focus on tailoring lens choices to individual needs and ocular co-morbidity. As a surgical innovator, Louisa is leading on the safe introduction of surgical innovation in the Trust. Her clinical team has previously been awarded a Patient Choice award at Moorfields, in addition her managed practice won “Best Ophthalmology Consultant 2016- London” in Corporate Vision Magazine.

Chien Wong

Mr Chien Wong

Consultant paediatric and adult retinal surgeon, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital

Speaker's biography

Mr Chien Wong is a consultant ophthalmologist and vitreoretinal (VR) surgeon in London, at Great Ormond Street Hospital for Children (GOSH), Royal Free and Moorfields Eye Hospital. He has a special interest in complex paediatric VR surgery and retinovascular diseases, in addition to his adult VR work.

 

Following ophthalmology residency at Moorfields Eye Hospital, he undertook VR and medical retina clinical fellowships also at Moorfields, and a further 3 years of paediatric VR and retinovascular clinical and research fellowships at Beaumont Hospital, Michigan, and Children’s Hospital Los Angeles, USA. He has been awarded over 15 prizes over his career and was recently inducted into the Retina Society.

 

In 2014, he transformed the treatment of retinopathy of prematurity (ROP) retinal detachment in the UK, by introducing a novel endoscopic vitrectomy approach. Subsequently, GOSH became the de facto UK national surgical centre for ROP-RD, in collaboration with Oxford University, with Mr Wong as the Head.

 

In 2017, he was named in the annual Power List, a global top 50 list of rising stars in ophthalmology.

 

His clinical and research interests include vitreoretinal surgery in adults and children, paediatric retinovascular diseases, genomic medicine and surgical approaches for gene therapy, surgical innovation and vitreoretinal surgical devices development. Dr Wong was the UK Chief Investigator and Moorfields Eye Hospital Principal Investigator for the RAINBOW randomised controlled trial. He is a co-investigator on several phase I/II gene therapy clinical trials. He has over 40 publications, has written numerous book chapters, and has run over 20 surgical courses including being the course director at the American Academy of Ophthalmology annual meeting of “Paediatric Vitreoretinal Disorders: Current & Future Management”.

 

He has worked closely with the Armenian EyeCare Project (AECP) since 2014, a not-for-profit California-based NGO supporting and developing eye care in Armenia since 1992. With over 10 trips to the country, he has trained the VR surgical team from the inception of the National Centre of Excellence for the Prevention of Childhood Blindness in Yerevan, Armenia, co-funded by AECP and the United States Agency for International Development.

Professor James Bainbridge

Consultant retinal surgeon at Moorfields Eye Hospital and NIHR Research Professor and Chair of Retinal Studies at the UCL Institute of Ophthalmology

Speaker's biography

James Bainbridge is a surgeon-scientist developing innovative gene and cell therapies for blinding eye disease. He has led the translation of gene therapies from proof of concept in experimental models to clinical trials for the benefit of people affected by inherited blindness. In 2007 he performed the pioneering world's first gene therapy for inherited eye disease, improving sight in adults and children (Bainbridge et al NEJM 2008). In 2018 he was a recipient of the €1m Champalimaud Vision Award, the World’s largest prize in vision research.

Agenda

View the programme here

Welcome and introduction
History of vitreoretinal surgery, robots and novel viewing systems

Ms Evgenia Anikina, Consultant Retinal Surgeon, Royal Berkshire NHS Trust

Small gauge surgery, intraocular lenses and complex eyes

Ms Louisa Wickham, Consultant Retinal Surgeon, Moorfields Eye Hospital

The cutting edge of paediatric retinal surgery – success in retinopathy of prematurity treatment

Mr Chien Wong, Consultant Paediatric and Adult Retinal Surgeon, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital

Retinal gene therapy – current experience and new frontiers

Prof James Bainbridge, Consultant Retinal Surgeon at Moorfields Eye Hospital and NIHR Research Professor and Chair of Retinal Studies at the UCL Institute of Ophthalmology

Close of meeting

Location

Online

Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM.

Special rates for difficult times 
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s COVID-19 online events are available free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic. 

Registration for this webinar will close 2 hours prior to the start time. Late registrations will not be accepted.

Webinar recordings will be available for registered delegates up to 30 days after the live webinar, via Zoom. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.